RCAMU
PFE icon

Rothschild & Co Asset Management US’s Pfizer PFE Stock Holding History

Rothschild & Co Asset Management US’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,374
Closed -$200K – 357
2019
Q4 		$200K Sell
5,374
-1,314,229
-100% -$46.8M ﹤0.01% 350
2019
Q3 		$45M Sell
1,319,603
-1,676,745
-56% -$61M 0.49% 51
2019
Q2 		$123M Sell
2,996,348
-91,837
-3% -$3.65M 1.31% 4
2019
Q1 		$124M Buy
3,088,185
+414,846
+16% +$16.6M 1.33% 6
2018
Q4 		$111M Buy
2,673,339
+153,516
+6% +$6.37M 1.34% 6
2018
Q3 		$105M Buy
2,519,823
+74,847
+3% +$2.88M 1.08% 7
2018
Q2 		$84.2M Buy
2,444,976
+8,462
+0.3% +$289K 0.9% 7
2018
Q1 		$82M Buy
2,436,514
+130,365
+6% +$4.48M 0.91% 6
2017
Q4 		$79.2M Sell
2,306,149
-70,137
-3% -$2.39M 0.84% 12
2017
Q3 		$80.5M Sell
2,376,286
-113,846
-5% -$3.66M 0.89% 10
2017
Q2 		$79.4M Sell
2,490,132
-14,549
-0.6% -$459K 0.9% 14
2017
Q1 		$81.3M Sell
2,504,681
-93,264
-4% -$2.94M 0.93% 11
2016
Q4 		$80.1M Buy
2,597,945
+371,097
+17% +$11.3M 1.02% 7
2016
Q3 		$71.6M Sell
2,226,848
-259,586
-10% -$8.68M 1.23% 4
2016
Q2 		$83.1M Sell
2,486,434
-164,508
-6% -$5.25M 1.5% 4
2016
Q1 		$74.5M Sell
2,650,942
-71,756
-3% -$2.05M 1.4% 5
2015
Q4 		$83.4M Buy
2,722,698
+47,772
+2% +$1.5M 1.52% 4
2015
Q3 		$79.7M Buy
2,674,926
+273,716
+11% +$8.78M 1.56% 5
2015
Q2 		$76.5M Buy
2,401,210
+40,406
+2% +$1.32M 1.41% 5
2015
Q1 		$77.9M Buy
2,360,804
+360,697
+18% +$11.5M 1.48% 3
2014
Q4 		$59.3M Sell
2,000,107
-107,026
-5% -$3.07M 1.18% 7
2014
Q3 		$59.3M Sell
2,107,133
-178,553
-8% -$5.01M 1.27% 9
2014
Q2 		$64.4M Buy
2,285,686
+198,900
+10% +$5.67M 1.32% 7
2014
Q1 		$63.6M Buy
2,086,786
+73,609
+4% +$2.19M 1.42% 5
2013
Q4 		$58.1M Sell
2,013,177
-377,767
-16% -$11M 1.29% 5
2013
Q3 		$65.2M Sell
2,390,944
-7,308
-0.3% -$199K 1.42% 4
2013
Q2 		$63.7M Buy
+2,398,252
New +$66.3M 1.48% 5

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Rothschild & Co Asset Management US's PFE Position: Q1 2020 in Review

Rothschild & Co Asset Management US sold out of Pfizer (PFE) in Q1 2020, closing a stake of 5,374 shares — an estimated $200K sold.

Rothschild & Co Asset Management US first reported a position in PFE in Q2 2013 and held it in 27 quarters. The position peaked at $124M in Q1 2019. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Rothschild & Co Asset Management US reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 5,374 Pfizer shares in Q1 2020, an estimated $200K.
  • Rothschild & Co Asset Management US first reported a position in Pfizer in Q2 2013 and held it in 27 quarters.
  • Rothschild & Co Asset Management US's Pfizer position peaked at $124M in Q1 2019.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2020, filed 14 May 2020.